These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26163401)

  • 1. Phenotypic resistance in mycobacteria: is it because I am old or fat that I resist you?
    Hammond RJ; Baron VO; Oravcova K; Lipworth S; Gillespie SH
    J Antimicrob Chemother; 2015 Oct; 70(10):2823-7. PubMed ID: 26163401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Methodologies for Detecting Phenotypic Resistance in Mycobacteria.
    Hammond RJH; Baron VO; Lipworth S; Gillespie SH
    Methods Mol Biol; 2018; 1736():85-94. PubMed ID: 29322461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting Phenotypically Resistant Mycobacterium tuberculosis Using Wavelength Modulated Raman Spectroscopy.
    Baron VO; Chen M; Clark SO; Williams A; Dholakia K; Gillespie SH
    Methods Mol Biol; 2018; 1736():41-50. PubMed ID: 29322457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro susceptibility of mycobacteria to ciprofloxacin.
    Collins CH; Uttley AH
    J Antimicrob Chemother; 1985 Nov; 16(5):575-80. PubMed ID: 2934361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis.
    Parrish NM; Kuhajda FP; Heine HS; Bishai WR; Dick JD
    J Antimicrob Chemother; 1999 Feb; 43(2):219-26. PubMed ID: 11252327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility testing for mycobacteria.
    Woods GL
    Clin Infect Dis; 2000 Nov; 31(5):1209-15. PubMed ID: 11073754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands.
    van Ingen J; van der Laan T; Dekhuijzen R; Boeree M; van Soolingen D
    Int J Antimicrob Agents; 2010 Feb; 35(2):169-73. PubMed ID: 20006470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly growing mycobacteria in Singapore, 2006-2011.
    Tang SS; Lye DC; Jureen R; Sng LH; Hsu LY
    Clin Microbiol Infect; 2015 Mar; 21(3):236-41. PubMed ID: 25658536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.
    Wang HX; Yue J; Han M; Yang JH; Gao RL; Jing LJ; Yang SS; Zhao YL
    Chin Med J (Engl); 2010 Jan; 123(2):184-7. PubMed ID: 20137367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].
    Janowiec M; Andrzejczyk Z; Marczewska J
    Pneumonol Pol; 1989 May; 57(5):300-7. PubMed ID: 2633149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Culture and susceptibility testing of mycobacteria with VersaTREK].
    Gravet A; Souillard N; Habermacher J; Moser A; Lohmann C; Schmitt F; Delarbre JM
    Pathol Biol (Paris); 2011 Feb; 59(1):32-8. PubMed ID: 20850229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between lipid composition and antibiotic-resistance to isoniazid, streptomycin, p-aminosalicylic acid, ethambutol, rifampicin in mycobacteria.
    Alberghina M
    Ital J Biochem; 1976; 25(2):127-51. PubMed ID: 962981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Galactosidase reporter system in mycobacteria and its application in rapid antimycobacterial drug screening.
    Srivastava R; Kumar D; Subramaniam P; Srivastava BS
    Biochem Biophys Res Commun; 1997 Jun; 235(3):602-5. PubMed ID: 9207204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of erm methylase genes in clinical isolates of non-pigmented, rapidly growing mycobacteria.
    Esteban J; Martín-de-Hijas NZ; García-Almeida D; Bodas-Sánchez A; Gadea I; Fernández-Roblas R
    Clin Microbiol Infect; 2009 Oct; 15(10):919-23. PubMed ID: 19438639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of alkynoic acids derivatives against mycobacteria.
    Vilchèze C; Leung LW; Bittman R; Jacobs WR
    Chem Phys Lipids; 2016 Jan; 194():125-38. PubMed ID: 26256431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment and drug susceptibility test of isoniazid resistant Mycobacterium smegmatis].
    Jia PP; Zhao LL; Li XY; Zhang Q; Liu ZL; Wang X; Yu LY; Zhao LX; Cen S
    Yao Xue Xue Bao; 2011 Apr; 46(4):377-82. PubMed ID: 21751489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation-drug resistance profile and molecular characterization of indigenous typical and atypical mycobacteria.
    Khanum T; Rasool SA; Ajaz M; Khan AI
    Pak J Pharm Sci; 2011 Oct; 24(4):527-32. PubMed ID: 21959816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gyrA and gyrB gene mutation in ciprofloxacin-resistant Mycobacterium massiliense clinical isolates from Southern Brazil.
    Monego F; Duarte RS; Biondo AW
    Microb Drug Resist; 2012 Feb; 18(1):1-6. PubMed ID: 21711149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.